Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Low-level Laser Therapy Versus Formocresol in Primary Molar Pulpotomies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03782714
Recruitment Status : Completed
First Posted : December 20, 2018
Last Update Posted : December 20, 2018
Sponsor:
Information provided by (Responsible Party):
Najlaa Alamoudi, King Abdulaziz University

Brief Summary:
This study aimed to assess and compare the clinical and radiographic success rates of LLLT and FC for pulpotomy in human primary teeth. One hundred and six primary molars from 36 children aging five to eight years were included and randomly assigned into two equal groups; LLLT group and FC group. Teeth were evaluated clinically and radiographically at 3, 6 and 12 months.

Condition or disease Intervention/treatment Phase
Pulpotomy Device: Low-level laser therapy Not Applicable

Detailed Description:

Background: Various agents are available to dress the remaining pulp tissue after pulpotomy procedure with the formocresol (FC) being the gold standard for the last 60 years. Nowadays, low-level laser therapy (LLLT) becomes a technique of interest, due to its many characteristics. However, the literature available on its success in pulpotomy is limited and reported conflicting results.

Aim of the study: To assess and compare the clinical and radiographic success rates of LLLT and FC for pulpotomy in human primary teeth.

Materials and methods: Utilizing split-mouth technique, the sample consisted of 106 primary molars from 36 children aging five to eight years. The teeth were selected based on specific clinical and radiographic inclusion criteria and randomly assigned into two equal groups; LLLT group and FC group. All the 106 primary molars were indicated for pulpotomy, where 53 teeth were treated using FC and 53 teeth were treated with LLLT. Teeth were evaluated clinically and radiographically at 3, 6 and 12 months.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 36 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: It is a split-mouth randomized controlled clinical trial
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Clinical and Radiographic Evaluation of Low-level Laser Therapy in Human Primary Molar Pulpotomies: A Randomized Controlled Clinical Trial
Actual Study Start Date : February 1, 2017
Actual Primary Completion Date : February 1, 2018
Actual Study Completion Date : February 1, 2018

Resource links provided by the National Library of Medicine

Drug Information available for: Formocresol

Arm Intervention/treatment
Experimental: Low-level laser therapy group
This group of teeth received laser irradiation after amputation of coronal pulp
Device: Low-level laser therapy
It is a diode laser device that has laser set at low level, used for pain relief and inflammation reduction to induce healing

No Intervention: Formocresol group
This group of teeth received the gold standard medication (formocresol) after coronal pulp amputation



Primary Outcome Measures :
  1. Clinical success rate [ Time Frame: 3 months ]
    The pulpotomy procedure was considered clinically successful if there were no pain, swelling, tenderness to percussion, abscess or abnormal mobility

  2. Clinical success rate [ Time Frame: 6 months ]
    The pulpotomy procedure was considered clinically successful if there were no pain, swelling, tenderness to percussion, abscess or abnormal mobility

  3. Clinical success rate [ Time Frame: 12 months ]
    The pulpotomy procedure was considered clinically successful if there were no pain, swelling, tenderness to percussion, abscess or abnormal mobility

  4. Radiographic success rate [ Time Frame: 3 months ]

    The pulpotomy procedure was considered clinically successful if it demonstrated the following criteria:

    1. Normal periodontal ligament space
    2. No inter-radicular or periapical radiolucency
    3. No internal or external root resorption

  5. Radiographic success rate [ Time Frame: 6 months ]

    The pulpotomy procedure was considered clinically successful if it demonstrated the following criteria:

    1. Normal periodontal ligament space
    2. No inter-radicular or periapical radiolucency
    3. No internal or external root resorption

  6. Radiographic success rate [ Time Frame: 12 months ]

    The pulpotomy procedure was considered clinically successful if it demonstrated the following criteria:

    1. Normal periodontal ligament space
    2. No inter-radicular or periapical radiolucency
    3. No internal or external root resorption



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   5 Years to 8 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Children inclusion criteria:

  • Children aged 5-8 years with at least two bilateral deep carious primary molars indicated for pulpotomy.
  • Children who are physically and mentally healthy without any known medical history of systemic conditions contraindicating pulp therapy.
  • Children who had "positive" or "definitely positive" behavioral ratings according to the Frankl behavior classification scale (Frankl, 1962).
  • Children whose parents signed an informed consent for the child's participation in the study.

Teeth inclusion criteria:

Teeth were selected according to clinical and radiographic criteria.

Clinically, the study included:

  • Teeth with restorable crowns
  • Teeth with pathologic carious exposure of vital pulps
  • Teeth with no tenderness to percussion, physiologic or pathologic mobility or any clinical evidence of pulp inflammation or degeneration such as history of swelling, pain or presence of sinus tract.

Radiographically, the recruited teeth should have:

  • Normal radiographic appearance with healthy supporting tissues
  • No pulp calcification
  • No internal or external root resorption
  • No periapical or inter-radicular radiolucency
  • At least two thirds of the root remaining (not more than one third of the root is physiologically resorbed)

Exclusion Criteria:

  • Any child complained of clinical signs such as pain, swelling, abnormal mobility, vertical or lateral tenderness to percussion was excluded from the study.
  • Radiographically, any child with signs of internal or external root resorption or periapical or inter-radicular pathology was omitted from the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03782714


Locations
Layout table for location information
Saudi Arabia
King Abdulaziz University, Dental University Hospital
Jeddah, Saudi Arabia, 21589
Sponsors and Collaborators
King Abdulaziz University
Layout table for additonal information
Responsible Party: Najlaa Alamoudi, Professor at the Pediatric Dentistry Department, King Abdulaziz University
ClinicalTrials.gov Identifier: NCT03782714    
Other Study ID Numbers: Alaa Nadhreen
First Posted: December 20, 2018    Key Record Dates
Last Update Posted: December 20, 2018
Last Verified: December 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Najlaa Alamoudi, King Abdulaziz University:
Low-level laser therapy, pulpotomy, formocresol